Skip to search formSkip to main contentSkip to account menu

fiduxosin

Known as: 3-(4-(9-methoxy-1,2,3,3a,4,9b-hexahydro(1)benzopyran(3,4-c)pyrrol-2-yl)butyl)-8-phenylpyrazino(2',3'-4,5)thieno(3,2-d)pyrimidine-2,4(1H,3H)-dione 
National Institutes of Health

Related topics

Related topics

3 relations

Narrower (1)

ABT 980

Broader (2)

Heterocyclic Compounds, 3-RingPyrimidinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
Fiduxosin is an alpha(1)-adrenoceptor antagonist with higher affinity for alpha(1A)-adrenoceptors and for alpha(1D)-adrenoceptors… 
2002
2002
Modeling of relationships between pharmacokinetics and blockade of agonist-induced elevation of intraurethral pressure and mean arterial pressure in conscious dogs treated with alpha(1)-adrenoceptor…
Fiduxosin is a new alpha(1)-adrenoceptor antagonist targeted for the treatment of symptomatic benign prostatic hyperplasia. The… 
2002
2002
Single-Dose Pharmacokinetics of Fiduxosin under Fasting Conditionsin Healthy Elderly Male Volunteers
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)